Kamada Ltd.
A biopharmaceutical company specializing in plasma-derived protein therapeutics.
KMDA | TA
Overview
Corporate Details
- ISIN(s):
- IL0010941198
- LEI:
- Country:
- Israel
- Address:
- 2 Holzman St, Science Park, 7670402 Rehovot
- Website:
- https://www.kamada.com
- Sector:
- Manufacturing
Description
Kamada Ltd. is a vertically integrated global biopharmaceutical company specializing in plasma-derived protein therapeutics. The company develops, manufactures, and commercializes a portfolio of products for rare and serious conditions, with a focus on therapeutic areas such as Alpha-1 Antitrypsin Deficiency (AATD) and Cytomegalovirus (CMV) prevention in transplant patients. Kamada utilizes a proprietary platform technology for advanced protein extraction and purification from human plasma. In addition to its marketed products, the company maintains a development pipeline of new therapies, including an inhaled treatment for AATD.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2023-11-13 16:05 |
ANNUAL GENERAL MEETING OF SHAREHOLDERS WILL BE HELD ON DECEMBER 28,2023
|
English | 202.1 KB | ||
| 2023-11-13 16:05 |
ANNUAL GENERAL MEETING OF SHAREHOLDERS WILL BE HELD ON DECEMBER 28,2023
|
English | 36.2 KB | ||
| 2023-11-13 15:23 |
Reports 2023 Third Quarter Financial Results
|
English | 11.9 MB | ||
| 2023-11-13 15:23 |
Reports 2023 Third Quarter Financial Results
|
English | 36.4 KB | ||
| 2023-11-13 15:19 |
The company's financial results for the Third quarter 2023 were published abroad
|
Hebrew (modern) | 102.0 KB | ||
| 2023-11-08 15:04 |
Kamada to Announce Third Quarter and First Nine Months Ended September 30, 2023…
|
English | 119.5 KB | ||
| 2023-11-08 15:04 |
Kamada to Announce Third Quarter and First Nine Months Ended September 30, 2023…
|
English | 36.4 KB | ||
| 2023-10-16 16:11 |
Announces Recent Achievements with CYTOGAM
|
English | 248.7 KB | ||
| 2023-10-16 16:11 |
Announces Recent Achievements with CYTOGAM
|
English | 36.5 KB | ||
| 2023-10-10 16:46 |
Kamada Provides Corporate Update on its Israel Operations
|
English | 183.0 KB | ||
| 2023-10-10 16:46 |
Kamada Provides Corporate Update on its Israel Operations
|
English | 36.0 KB | ||
| 2023-09-11 16:07 |
Prospectus $50,000,000 Ordinary Shares Offered by the Company or Announcement
|
English | 685.7 KB | ||
| 2023-09-11 16:07 |
Prospectus $50,000,000 Ordinary Shares Offered by the Company or Announcement
|
English | 36.0 KB | ||
| 2023-08-30 16:34 |
Kamada Announces Shareholder Approval and Planned Closing of $60 Million Privat…
|
English | 752.6 KB | ||
| 2023-08-30 16:34 |
Kamada Announces Shareholder Approval and Planned Closing of $60 Million Privat…
|
English | 36.2 KB |
Automate Your Workflow. Get a real-time feed of all Kamada Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Kamada Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Kamada Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
